| |
| |
|
| Insider
Information: |
Buchi J Kevin |
| Relationship: |
Director |
| City: |
West Chester |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
174,797 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$319,374 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
174,797 |
|
|
| Total
Value |
$319,374 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -63.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cephalon Inc |
CEPH |
Chief Executive Office... |
2011-10-14 |
0 |
2011-10-14 |
0 |
Premium* |
|
|
Encysive Pharmaceuticals Inc |
ENCY |
Director |
2008-04-01 |
0 |
2007-04-02 |
0 |
Premium* |
|
|
Stemline Therapeutics Inc |
STML |
Director |
2015-06-23 |
23,772 |
|
0 |
Premium* |
|
|
Impax Laboratories Inc |
IPXL |
Director |
2018-05-04 |
0 |
2016-11-23 |
0 |
Premium* |
|
|
Alaunos Therapeutics |
TCRT |
Director |
2021-03-04 |
4,167 |
2021-03-04 |
0 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
Director |
2021-12-28 |
0 |
2021-06-03 |
0 |
Premium* |
|
|
Ampio Pharmaceuticals Inc |
AMPE |
Director |
2023-06-09 |
146,858 |
2023-05-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMPE |
Ampio Pharmaceuticals Inc |
Director |
– • – |
2023-06-09 |
4 |
B |
$0.29 |
$6,284 |
D/D |
21,858 |
146,858 |
2.39 |
% |
|
| AMPE |
Ampio Pharmaceuticals Inc |
Director |
– • – |
2023-06-08 |
4 |
B |
$0.30 |
$7,400 |
D/D |
25,000 |
125,000 |
2.39 |
% |
|
| AMPE |
Ampio Pharmaceuticals Inc |
Director |
– • – |
2023-05-16 |
4 |
B |
$0.27 |
$8,924 |
D/D |
32,534 |
100,000 |
2.39 |
% |
|
| AMPE |
Ampio Pharmaceuticals Inc |
Director |
– • – |
2023-05-15 |
4 |
B |
$0.25 |
$10,857 |
D/D |
44,026 |
67,466 |
2.39 |
% |
|
| AMPE |
Ampio Pharmaceuticals Inc |
Director |
– • – |
2023-05-12 |
4 |
B |
$0.24 |
$5,513 |
D/D |
23,440 |
23,440 |
2.39 |
% |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-12-28 |
4 |
D |
$38.25 |
$178,475 |
D/D |
(4,666) |
0 |
0 |
- |
|
| DRNA |
Dicerna Pharmaceuticals I... |
Director |
– • – |
2021-06-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,666 |
4,666 |
0 |
- |
|
| TCRT |
Alaunos Therapeutics |
Director |
– • – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
4,167 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Director |
– • – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,281) |
0 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Director |
– • – |
2018-05-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,020) |
0 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Director |
– • – |
2017-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,281 |
11,301 |
0 |
- |
|
| IPXL |
Impax Laboratories Inc |
Director |
– • – |
2016-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
8,020 |
8,020 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2015-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,772 |
0 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2013-01-29 |
4 |
B |
$10.00 |
$5,000 |
D/D |
500 |
13,772 |
2.39 |
- |
|
| STML |
Stemline Therapeutics Inc |
Director |
– • – |
2013-01-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
13,272 |
|
- |
|
| CEPH |
Cephalon Inc |
Chief Executive Officer |
• • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,592) |
0 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Executive Officer |
• • – |
2011-10-14 |
4 |
D |
$0.00 |
$0 |
D/D |
(172,962) |
0 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Executive Officer |
• – – |
2011-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
100,462 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Operating Officer |
• – – |
2010-12-20 |
4 |
D |
$64.67 |
$104,571 |
D/D |
(1,617) |
109,146 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Operating Officer |
• – – |
2010-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
110,763 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Operating Officer |
• – – |
2010-12-13 |
4 |
D |
$62.95 |
$203,580 |
D/D |
(3,234) |
80,763 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Executive Officer |
• • – |
2010-12-02 |
4/A |
D |
$65.51 |
$81,363 |
D/D |
(1,242) |
55,313 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Exec. V.P., CFO |
• – – |
2010-12-02 |
4 |
D |
$65.51 |
$81,363 |
D/D |
(1,242) |
83,997 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Operating Officer |
• – – |
2010-03-05 |
4 |
OE |
$51.13 |
$1,533,750 |
D/D |
30,000 |
115,239 |
0 |
- |
|
| CEPH |
Cephalon Inc |
Chief Operating Officer |
• – – |
2010-03-05 |
4 |
S |
$70.64 |
$2,119,200 |
D/D |
(30,000) |
85,239 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
